Emerging Pharmacotherapy to Reduce Elevated Lipoprotein(a) Plasma Levels
Nathaniel Eraikhuemen, Dovena Lazaridis, Matthew Dutton
Topics & Concepts
KexinLipoproteinPCSK9MedicineCholesterylester transfer proteinProprotein convertaseParaoxonaseLipoprotein(a)Apolipoprotein BPharmacologyInternal medicinePON1PharmacotherapyCoronary artery diseaseEndocrinologyCholesterolChemistryLDL receptorBiochemistryOxidative stressGenotypeGeneLipoproteins and Cardiovascular HealthCancer, Lipids, and MetabolismDiabetes, Cardiovascular Risks, and Lipoproteins